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Congenital Heart Disease
Surgery in Adults With Congenital Heart Disease
A.C. Zomer, MD; C.L. Verheugt, MD, PhD; I. Vaartjes, PhD; C.S.P.M. Uiterwaal, MD, PhD;
M.M. Langemeijer, MSc; D.R. Koolbergen, MD, PhD; M.G. Hazekamp, MD, PhD;
J.P. van Melle, MD, PhD; T.C. Konings, MD; L. Bellersen, MD;
D.E. Grobbee, MD, PhD; B.J.M. Mulder, MD, PhD
Background—A significant proportion of patients with congenital heart disease require surgery in adulthood. We aimed
to give an overview of the prevalence, distribution, and outcome of cardiovascular surgery for congenital heart disease.
We specifically questioned whether the effects of surgical treatment on subsequent long-term survival depend on sex.
Methods and Results—From the Dutch Congenital Corvitia (CONCOR) registry for adults with congenital heart disease,
we identified 10 300 patients; their median age was 33.1 years. Logistic and Cox regression models were used to assess
the association of surgery in adulthood with sex and with long-term survival. In total, 2015 patients (20%) underwent
surgery for congenital heart disease in adulthood during a median follow-up period of 15.1 years; in 812 patients (40%),
it was a reoperation. Overall, both first operations and reoperations in adulthood were performed significantly more
often in men compared with women (adjusted odds ratio1.4 [95% confidence interval, 1.2–1.6] and 1.2 [95%
confidence interval, 1.0–1.4], respectively). Patients with their third and fourth or more surgery in adulthood had a 2-
and 3-times-higher risk of death compared with patients never operated on (adjusted hazard ratio1.9 [95% confidence
interval, 1.0–3.6] and 2.7 [95% confidence interval, 1.1–6.3], respectively). Men with a reoperation in adulthood had
a 2-times-higher risk of death than women (adjusted hazard ratio1.9; 95% confidence interval, 1.0–3.5).
Conclusions—Of predominantly young adults with congenital heart disease, one fifth required cardiovascular surgery
during a 15-year period; in 40%, the surgery was a reoperation. Men with congenital heart disease have a higher chance
of undergoing surgery in adulthood and have a consistently worse long-term survival after reoperations in adulthood
compared with women. (Circulation. 2011;124:2195-2201.)
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Over the past decades, the number of adults with congen-ital heart disease has increased, and is currently esti-
mated at 1 million in the United States and 1.2 million in
Europe.1–3 As a result of tremendous advancements in car-
diothoracic surgery in the past decades, 95% of newborns
with congenital heart disease now survive to adulthood.4
However, despite these major advancements, a significant
proportion of this patient population will have to undergo
cardiovascular surgery at some point in adulthood, either for
first corrective surgery or for reoperations to treat residual
defects or long-term complications.5–9 Although there has
been rapid growth recently in interventional cardiology tech-
niques to treat adults with congenital heart disease,10 surgery
remains an important treatment option, with 1 of 5 hospital
admissions of adults with congenital heart disease being for
cardiovascular surgery.11–13
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In recent years, there has been increased attention on sex
differences in cardiovascular disease because it has been
recognized that men and women differ in clinical manifesta-
tion, morbidity, mortality, and the way they are managed.14–16
Few data exist on sex differences in adults with congenital
heart disease. However, our research group and others have
previously shown that men appear to have a higher risk of
long-term complications and mortality.17,18 Whether there is
an effect of sex on surgical treatment and outcome after
surgery is still unknown.
We used the Dutch nationwide Congenital Corvitia
(CONCOR) registry to give an overview of the prevalence,
distribution, and outcome of cardiovascular surgery for
congenital heart disease in adulthood. Furthermore, we
sought to determine the effects of sex on the risk of
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surgical treatment and on long-term survival after surgery
in adulthood.
Methods
CONCOR Registry
The Dutch national registry database has been described in detail
elsewhere.19 Briefly, CONCOR aims to facilitate research into the
cause of congenital heart disease and on its outcome. From Novem-
ber 2001, patients with congenital heart disease 18 years of age
(childhood survivors) were recruited and included by 3 independent,
permanently employed research nurses through the treating cardiol-
ogist or via response to advertisements in local media. Clinical data
such as demographics, diagnosis, clinical events, and procedures
(classified by use of the European Pediatric Cardiac Code Short List
coding scheme20), as well as patient and family history, were
obtained from medical records. In case of multiple diagnoses in 1
patient, a prespecified hierarchical scheme founded on consensus-
based classification of defect severity21 was used, by means of which
the diagnosis with the worst prognosis was established as the main
diagnosis. After entry, data on major cardiac events before entry and
during follow-up were systematically recorded from the patients’
medical letters written by their cardiologist. Quality control of data
was performed by randomly verifying 10% of data yearly. Cur-
rently, 103 Dutch hospitals are participating, including all 8 tertiary
referral centers from which 70% of patients originate.
Surgery Data
For all patients, the occurrence, date, and type of intervention for
congenital heart disease were collected retrospectively. All interven-
tions for congenital heart disease were divided into surgical (defined
as requiring either sternotomy or thoracotomy for cardiac or aortic
surgery) or percutaneous interventions. Reoperations were recorded
as multiple surgical interventions within the same patient on different
dates of surgery. Thus, multiple surgical interventions on the same
date of surgery were counted as 1 operation. Moreover, all operations
were categorized as corrective or palliative. Corrective operations
were defined as surgical interventions with the aim to repair or treat
underlying congenital heart defects. Palliative operations were de-
fined as surgical interventions performed to improve clinical toler-
ance and alleviate serious symptoms of congenital heart defects that
could not be repaired otherwise, including bidirectional cavopulmo-
nary anastomosis (Glenn), shunts, and Norwood and Fontan
procedures.
Data Analysis
Age at time of inclusion, age at time of surgery, and age at time of
death were summarized with medians (range limits). Follow-up
Table 1. Basic Characteristics of the Overall CONCOR Population (n10 300), Patients With a Surgical Intervention (n2015),
Patients With a Percutaneous Intervention (n808), and Patients Without an Intervention (n7775) in Adulthood
CONCOR
(n10 300)
n
Surgical Intervention (n2015, 19.6%)
Percutaneous
Intervention
(n808, 7.8%)
First Surgery in
Adulthood (n1416)
Reoperation in
Adulthood* (n812)
No Intervention
(n7775, 75.5%)
n % n % n % n %
Patient characteristics
Male 5064 745 15 429 9 371 7 3784 75
Female 5236 671 13 373 7 437 8 3991 76
Age, y† 33.1 (18.0–92.2) 49.0 (18.8–90.6) 40.4 (18.1–84.1) 42.5 (18.8–89.7) 29.6 (18.0–92.2)
Main defects
VSD 1749 113 6 54 3 63 4 1553 89
ASD 1552 421 27 55 4 258 17 926 60
CoA 1010 118 12 135 13 58 6 754 75
TOF 942 45 5 193 20 101 11 672 71
AoS 929 196 21 116 12 37 4 645 69
PS 784 26 3 27 3 41 5 700 89
BAV 558 130 23 14 3 21 4 419 75
AVSD 478 72 15 43 9 30 6 367 77
Marfan 462 139 30 35 8 7 2 314 68
TGA 451 5 1 24 5 60 13 374 83
PDA 164 11 7 5 3 21 13 132 80
Ebstein 154 23 15 11 7 24 16 109 71
PAVSD 118 3 3 20 17 7 6 92 78
ccTGA 117 8 7 6 5 19 16 87 74
UVH/DILV 107 6 6 8 7 15 14 83 78
Other 725 100 14 66 9 46 6 548 76
CONCOR indicates Congenital Corvitia; VSD, ventricular septal defect; ASD, atrial septal defect; CoA, aortic coarctation; TOF, tetralogy of Fallot; AoS, aortic stenosis;
PS, pulmonary stenosis; BAV, bicuspid aortic valve; AVSD, atrioventricular septal defect (including ASD, primum type); Marfan, Marfan syndrome; TGA, transposition
of the great arteries; PDA, patent arterial duct; Ebstein, Ebstein anomaly; PA, pulmonary atresia; ccTGA, congenitally corrected TGA; UVH/DILV, univentricular
heart/double-inlet left ventricle; and other, other congenital heart defects with n100. Percentages are calculated within rows.
*Two hundred thirteen subjects with both first-time surgery and reoperations in adulthood appear in both columns of surgical intervention; 298 subjects with both
surgical interventions and percutaneous interventions in adulthood appear in both columns.
†Age is at the time of inclusion and is stated as median with range limits.
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duration for surgery in adulthood was calculated from the 18th
birthday to the date of inclusion. Follow-up duration for survival was
calculated from date of inclusion to either the time of analysis (April
4, 2009) or death. For distribution of congenital heart defects, defects
experienced by at least 100 patients were included to give an
overview. Frequencies of interventions were calculated in total and
by defect. We assessed the association between sex and surgery in
adulthood using logistic regression models, from which we present
odds ratios and 95% confidence intervals (CIs) after adjustment for
age at inclusion, defect, multiple defects, and childhood operations.
Furthermore, we assessed the association of surgery in adulthood
(first-time surgery and reoperation) with long-term survival and of
sex with long-term survival using Cox regression models, from
which we present hazard ratios and 95% CIs after adjustment for age
at inclusion, defect, and multiple defects. For assessment of long-
term survival, reoperations in adulthood were stratified according to
the number of surgeries performed in the medical history. Perioper-
ative mortality (death during or within 30 days after surgery) was
assessed in a subset of patients using prospective data (n536). We
used SPSS version 17.0 (SPSS Inc, Chicago, IL) for analysis.
Results
Of 10 300 adult congenital heart disease patients, 5064 (49%)
were male, and the median age was 33.1 years (range limits,
18.0–92.2 years) at the time of inclusion. During a median
follow-up period of 15.1 years (range limits, 0.0–74.2 years),
a total of 3466 interventions were performed in 2525 patients
(24.5%) at adult age. Of these interventions, 2404 (69%) were
surgical; these were performed in 2015 patients. Among these
patients, 254 (13%) underwent surgery twice in adulthood, 52
(3%) had surgery 3 times, and 10 (0.5%) underwent surgery
4 times.
Table 1 shows the basic characteristics of the overall
CONCOR population and of patients who had a surgical
intervention, who had a percutaneous intervention, and who
were without an intervention in adulthood. In total, 2015
patients underwent surgery in adulthood; in 812 patients
(40%), it was a reoperation. Approximately one third of
patients with an atrial septal defect and Marfan syndrome had
surgery in adulthood for the first time ever. Most reoperations
in adulthood were seen in tetralogy of Fallot patients (20%);
in this group, 37% of reoperations were pulmonary valve
replacements. More than 15% of patients with congenitally
corrected transposition of the great arteries underwent a
percutaneous intervention in adulthood, primarily for pace-
maker implantation.
Frequencies of first operations and of reoperations in
adulthood in men and women are shown in Table 2. Overall,
Table 2. Frequencies of First Operations and Reoperations in Adulthood in All Male and Female Patients per Defect
Male Patients Female Patients
CONCOR
(n5064)
n
First Surgery
in Adulthood
(n745,
14.7%*)
Reoperation in Adulthood†
(n439, 8.7%‡) CONCOR
(n5236)
n
First Surgery
in Adulthood
(n671,
12.8%‡)
Reoperation in Adulthood†
(n373, 7.1%‡)
Main Defects n % n % Mean Reoperations n % n % Mean Reoperations
VSD 767 61 8.0* 34 4.4‡ 1.3 982 52 5.3* 20 2.0‡ 1.4
ASD 539 147 27.3 19 3.5 1.1 1013 274 27.0 36 3.6 1.2
CoA 605 79 13.1 100 16.5‡ 1.2 405 39 9.6 35 8.6‡ 1.2
TOF 516 25 4.8 92 17.8 1.3 426 20 4.7 101 23.7 1.3
AoS 588 120 20.4 68 11.6 1.3 341 76 22.3 48 14.1 1.5
PS 318 11 3.5 7 2.2 1.1 466 15 3.2 20 4.3 1.2
BAV 372 101 27.2* 11 3.0 1.6 186 29 15.6* 3 1.6 1.0
AVSD 196 30 15.3 22 11.2 1.3 282 42 14.9 21 7.4 1.2
Marfan 237 88 37.1* 20 8.4 1.6 225 51 22.7* 15 6.7 1.4
TGA 294 4 1.4 15 5.1 1.5 157 1 0.6 9 5.7 1.0
PDA 38 2 5.3 2 5.3 1.0 126 9 7.1 3 2.4 1.0
Ebstein 68 8 11.8* 3 4.4 1.7 86 15 17.4* 8 9.3 1.5
PAVSD 52 1 1.9 8 15.4 1.6 66 2 3.0 12 18.2 1.3
ccTGA 75 8 10.7 4 5.3 1.3 42 0 0.0 2 4.8 1.0
UVH/DILV 60 2 3.3 5 8.3 1.4 47 4 8.5 3 6.4 1.3
Other 339 58 17.1 29 8.6 1.4 386 42 10.9 37 9.1 1.3
CONCOR indicates Congenital Corvitia; VSD, ventricular septal defect; ASD, atrial septal defect; CoA, aortic coarctation; TOF, tetralogy of Fallot; AoS, aortic stenosis;
PS, pulmonary stenosis; BAV, bicuspid aortic valve; AVSD, atrioventricular septal defect (including ASD, primum type); Marfan, Marfan syndrome; TGA, transposition
of the great arteries; PDA, patent arterial duct; Ebstein, Ebstein anomaly; PA, pulmonary atresia; ccTGA, congenitally corrected TGA; UVH/DILV, univentricular
heart/double-inlet left ventricle; and other, other congenital heart defects with n100. Percentages are calculated within rows.
*After adjustment for age, defect, multiple defects, and childhood operation, the difference between first surgery in adulthood in male and female patients is
significant (P0.05).
†Reoperation in adulthood means a surgery after a first surgery in childhood (male patients, n314; female patients, n285) or after a first surgery in adulthood
(male patients, n125; female patients, n88).
‡After adjustment for age, defect, multiple defects, and number of childhood operations, difference between reoperations in adulthood in male and female patients
is significant (P0.05).
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both first surgery and reoperations in adulthood were per-
formed significantly more often in men compared with
women (after adjustment for age, defect, multiple defects, and
childhood operations, odds ratio1.4 [95% CI, 1.2–1.6] for
first surgery and 1.2 [95% CI, 1.0–1.4] for reoperations). This
higher rate of reoperations in men compared with women was
driven primarily by the higher reoperation rate in men with
ventricular septal defect (odds ratio2.3; 95% CI, 1.3–4.1)
and aortic coarctation (odds ratio1.9; 95% CI, 1.3–3.0).
Perioperative mortality was assessed in 536 patients who
had 824 surgeries during a median follow-up of 3.8 years in
CONCOR (Table 3). In 160 patients (30%), the operation was
their first surgery. Of 536 patients, 27 (5%) died during
follow-up; 18 died perioperatively (3.4%). Perioperative mor-
tality was higher after palliative surgery than after corrective
surgery (P0.001) and was highest among patients with
univentricular heart (25%), transposition of the great arteries
(17%), and other defects (8%).
The Figure shows survival curves of adult patients who
were never operated on, those who had their first surgery in
adulthood, and patients who had their second, third, or fourth
or more surgery in adulthood. For patients who had their first
surgery in adulthood, the risk of death during a median
follow-up period of 3.8 years was comparable to that of
patients who were never operated on. For patients who had
their third and fourth or more surgery in adulthood, the risk of
death was nearly 2 and 3 times higher compared with patients
never operated on (hazard ratio1.9 [95% CI, 1.0–3.6] and
2.7 [95% CI, 1.1–6.3[, respectively). Men with a reoperation
in adulthood had a 2-times-higher risk of death compared
with women (hazard ratio1.9; 95% CI 1.0–3.5; Table 4).
Discussion
During a median follow-up of 15.1 years, one fifth of patients
with congenital heart disease required surgery in adulthood,
and in nearly 40%, it was a reoperation. Long-term survival
after reoperations in adulthood depends on the number of
surgeries performed in the patient’s history. Additionally,
this is the first study showing that male patients with
congenital heart disease have a higher chance of undergo-
ing surgery in adulthood and, remarkably, have a worse
long-term survival after reoperations in adulthood com-
pared with female patients.
A large proportion of patients (70%) who required surgery
in adulthood were operated on for the first time ever. In
concordance with current literature, these patients were
mostly adults with atrial septal defect and aortic stenosis.5,6
Furthermore, one third of Marfan patients had their first
surgery in adulthood, which also is in agreement with the
previously reported data.22 Focusing on the reoperations,
patients with tetralogy of Fallot formed the largest subgroup
needing reoperations in adulthood. Although tetralogy of
Fallot patients are known for their need of reoperations, none
of the previous published literature23–25 reported a reoperation
rate this high. However, this could be explained by the fact
that the follow-up period was longer in this study than in
reported series. The overall perioperative mortality was 3.4%
in our study, which is comparable to the mortality rates
reported previously.5,26,27 The mortality rate was low for
corrective surgery but high for palliative surgery, which is
also in agreement with current literature.5,27
Even after adjustment for childhood operations, defect, and
multiple defects, male patients with congenital heart disease
had more surgery in adulthood than female patients for both
first-time surgery and reoperation. Sex-related differences in
use of procedures have been well documented for adults with
acquired cardiovascular disease,14,15 but data in the adult
congenital heart disease population are sparse.17 The higher
operation rate in men with Marfan syndrome and bicuspid
aortic valve compared with women could be a result of
biological differences. Both defects are associated with aortic
complications, but male patients reach the threshold for
elective aortic surgery earlier than female patients because
Table 3. Basic Characteristics of Patients Who Underwent
Surgery (n536) During a Median Follow-Up Period of 3.8
Years and of Patients Who Died Perioperatively (n18)
Operated
(n536)
n
Perioperative Mortality
(n18, 3.4%)
n %
Patient characteristics
Male 307 8 2.6
Female 229 10 4.3
Age at death, y … 43.4 (20.8–77.8)
Multiple defects 390 13 3.3
Last surgery
Age at surgery, y 34.5 (18.0–77.8) 34.6 (20.8–77.8)
First surgery 160 3 1.9
Reoperation 376 15 4.0
Second surgery 202 7 3.4
Third surgery 116 4 3.4
Fourth surgery or more 58 4 6.8
Corrective 518 13 2.5
Palliative 18 5 27.8
Main defects*
TOF 115 1 0.8
AoS 81 3 3.6
ASD 54 2 3.7
CoA 47 1 2.1
PS 23 1 4.3
Ebstein 15 1 6.7
UVH/DILV 12 3 25.0
BAV 12 1 8.3
TGA 6 1 16.7
Other 50 4 8.0
TOF indicates tetralogy of Fallot; AoS, aortic stenosis; ASD, atrial septal
defect; CoA, aortic coarctation; PS, pulmonary stenosis; Ebstein, Ebstein
anomaly; UVH/DILV, univentricular heart/double-inlet left ventricle; BAV, bicus-
pid aortic valve; TGA, transposition of the great arteries; and other, other
congenital heart defects with n100. Age at death and age at surgery is stated
as median (range limits). Percentages are calculated within rows.
*One hundred twenty-one patients with Marfan syndrome (n43), ventric-
ular septal defect (n31), atrioventricular septal defect (n30), congenitally
corrected TGA (n8), pulmonary atresia with ventricular septal defect (n6),
and patent arterial duct (n3) were operated on without perioperative deaths.
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the aorta is smaller is female patients.28–31 Furthermore,
sex-related complications in adult congenital heart disease
patients18,32 could explain the larger reoperation rate in men
with aortic coarctation compared with women. Because men
with aortic coarctation have a higher prevalence of aortic
valve disease than women, they have a higher chance of being
operated on.32,33 Other explanations might be genetic, life-
style, and healthcare behavior differences between male and
female patients. Finally, we cannot exclude the possibility
that women are in some degree undertreated or alternatively
that men are overtreated, as has been suggested in other
cardiovascular diseases.14,15
Long-term survival for patients with reoperations in adult-
hood inversely correlated with the number of surgeries in the
patient’s medical history. Furthermore, a new finding was
that the risk of long-term mortality after a reoperation in
adulthood was higher for male patients compared with female
patients, a finding that is supported by the published literature
on overall long-term survival in patients with congenital heart
disease.13,17,34 An increased incidence of severe congenital
heart disease lesions in male patients35 cannot explain these
interesting results because we adjusted for underlying defect.
However, it is likely that the previously mentioned sex-
related complications and perhaps other comorbid conditions
play a role in both the higher (re)operation rate and the worse
prognosis after reoperation in male patients.
Implications
One fifth of patients with congenital heart disease underwent
surgery in adulthood. However, taking into account the low
median age of the patients with no intervention in adulthood,
it is to be expected that the prevalence of surgery in adulthood
will be even higher with longer follow-up. The high rate of
reoperations supports the hypothesis that corrective surgery is
not necessarily curative surgery, and thorough follow-up is
needed in these patients. Furthermore, our data indicate that
male and female patients born with a congenital heart defect
differ in the way they are (surgically) managed, at least in
frequency. Cardiologists should be aware of this existing
difference in treatment. Whether this relates to biological,
genetic, or behavioral differences between male and female
patients with congenital heart disease remains uncertain, but
large prospective studies are necessary to confirm our find-
ings, to assess underlying mechanisms, and to assess whether
this is appropriate clinical practice.
Figure. Survival curves of adult patients who were never operated on (reference group), who had their first surgery in adulthood, and
who had their second, third, fourth, or more surgery in adulthood. Hazard ratios (HR) (95% confidence interval) are for a median
follow-up period of 3.8 years; they are shown after adjustment for age at inclusion, underlying defect, and multiple defects. CONCOR
indicates Congenital Corvitia.
Table 4. Sex Differences in Risk of Death in Patients Who
Were Never Operated on, Who Had Their First Surgery in
Adulthood, and Who Had Their Second or Third or More
Surgery in Adulthood
Surgery in Adulthood HR (95% CI)*
No surgery at all 1.84 (1.21–2.78)
First-time surgery 0.97 (0.60–1.59)
Reoperation 1.89 (1.02–3.50)
Second surgery 1.10 (0.47–2.55)
Third or more surgery† 3.78 (1.33–10.79)
*Hazard ratio (HR) (95% confidence interval CI) for a median follow-up
period of 3.8 years, males vs females. HRs are shown after adjustment for age
of inclusion, underlying defect, and multiple defects.
†Because of the small number in the category of4 surgeries, this category
could not be validly analyzed separately; therefore, it was combined with the
category of 3 surgeries.
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Although long-term survival after a patient’s first and
second surgeries in adulthood is relatively high, long-term
survival for patients with after 3 surgeries in adulthood is
reduced. Interestingly, long-term survival after reoperations
seems worse for men compared with female patients.
Whether this is a reflection of the natural clinical course in
male and female patients with congenital heart disease or of
other underlying mechanisms that are playing a role needs to
be investigated further. Data from international databases on
congenital heart surgery could be of additional value.36
Limitations
The patients included in CONCOR form a survival cohort
because patients who died before enrollment could not be
included. The results of this study should be interpreted in
this context. Furthermore, this study covers a long period of
time, during which treatment algorithms, follow-up, and
surgical and perioperative management changed consider-
ably. Finally, the association of sex with surgery and long-
term survival may be a reflection of sex-linked characteristics
not included in the CONCOR database, such as healthcare
behavior or comorbid conditions. However, in another study
(A.C.Z., unpublished data, 2011), we found no differences in
smoking status, diabetes mellitus, and obesity between male
and female patients, suggesting a limited contribution of these
comorbid conditions to the association found.
Conclusions
Of predominantly young adults with congenital heart disease,
one fifth required surgery during 15 years of follow-up, and
in nearly 40%, this surgery was for reoperations. Overall,
long-term survival after reoperations in adulthood depended
on the number of past surgeries. Male patients with congen-
ital heart disease have a higher chance of undergoing surgery
in adulthood and have a consistently worse long-term sur-
vival after reoperations in adulthood compared with female
patients.
Sources of Funding
The CONCOR project and the performance of this study are funded
by the Interuniversity Cardiology Institute of the Netherlands and the
Netherlands Society of Cardiology. The study design, data manage-
ment, data analysis, data interpretation, writing of the paper, and
decision to submit the paper for publication were independent of the
funding organizations.
Disclosures
None.
References
1. Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart
disease. Am Heart J. 2004;147:425–439.
2. Moons P, Engelfriet P, Kaemmerer H, Meijboom FJ, Oechslin E, Mulder
BJ. Delivery of care for adult patients with congenital heart disease in
Europe: results from the Euro Heart Survey. Eur Heart J. 2006;27:
1324–1330.
3. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults:
first of two parts. N Engl J Med. 2000;342:256–263.
4. Warnes CA. The adult with congenital heart disease: born to be bad? J Am
Coll Cardiol. 2005;46:1–8.
5. Vida VL, Berggren H, Brawn WJ, Daenen W, Di Carlo D, Di Donato R,
Lindberg HL, Corno AF, Fragata J, Elliott MJ, Hraska V, Kiraly L,
Lacour-Gayet F, Maruszewski B, Rubay J, Sairanen H, Sarris G, Urban
A, Van DC, Ziemer G, Stellin G. Risk of surgery for congenital heart
disease in the adult: a multicentered European study. Ann Thorac Surg.
2007;83:161–168.
6. Daebritz SH. Update in adult congenital cardiac surgery. Pediatr Cardiol.
2007;28:96–104.
7. Verheugt CL, Uiterwaal CS, Grobbee DE, Mulder BJ. Long-term
prognosis of congenital heart defects: a systematic review. Int J Cardiol.
2008;131:25–32.
8. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ,
Mulder BJ. The changing epidemiology of congenital heart disease. Nat
Rev Cardiol. 2011;8:50–60.
9. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG,
Veen G, Stappers JL, Grobbee DE, Mulder BJ. Turning 18 with con-
genital heart disease: prediction of infective endocarditis based on a large
population. Eur Heart J. 2011;32:1926–1934.
10. MacDonald ST, Carminati M, Chessa M. Managing adults with con-
genital heart disease in the catheterization laboratory: state of the art.
Expert Rev Cardiovasc Ther. 2010;8:1741–1752.
11. Somerville J. Management of adults with congenital heart disease: an
increasing problem. Annu Rev Med. 1997;48:283–293.
12. Stellin G, Vida VL, Padalino MA, Rizzoli G. Surgical outcome for
congenital heart malformations in the adult age: a multicentric European
study. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:
95–101.
13. Billett J, Majeed A, Gatzoulis M, Cowie M. Trends in hospital
admissions, in-hospital case fatality and population mortality from con-
genital heart disease in England, 1994 to 2004. Heart. 2008;94:342–348.
14. Ayanian JZ, Epstein AM. Differences in the use of procedures between
women and men hospitalized for coronary heart disease. N Engl J Med.
1991;325:221–225.
15. Healy B. The Yentl syndrome. N Engl J Med. 1991;325:274–276.
16. Stramba-Badiale M. Women and research on cardiovascular diseases in
Europe: a report from the European Heart Health Strategy (EuroHeart)
project. Eur Heart J. 2010;31:1677–1681.
17. Engelfriet P, Mulder BJ. Gender differences in adult congenital heart
disease. Neth Heart J. 2009;17:414–417.
18. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG,
Vliegen HW, van Dijk AP, Bouma BJ, Grobbee DE, Mulder BJ. Gender
and outcome in adult congenital heart disease. Circulation. 2008;118:
26–32.
19. van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R,
Mulder BJ. CONCOR, an initiative towards a national registry and
DNA-bank of patients with congenital heart disease in the Netherlands:
rationale, design, and first results. Eur J Epidemiol. 2005;20:549–557.
20. Franklin RC, Anderson RH, Daniels O, Elliott MJ, Gewillig MH, Ghisla
R, Krogmann ON, Ulmer HE, Stocker FP. Report of the Coding Com-
mittee of the Association for European Paediatric Cardiology. Cardiol
Young. 2002;12:611–618.
21. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI,
Somerville J, Williams RG, Webb GD. Task Force 1: the changing profile
of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37:
1170–1175.
22. Cameron DE, Alejo DE, Patel ND, Nwakanma LU, Weiss ES, Vricella
LA, Dietz HC, Spevak PJ, Williams JA, Bethea BT, Fitton TP, Gott VL.
Aortic root replacement in 372 Marfan patients: evolution of operative
repair over 30 years. Ann Thorac Surg. 2009;87:1344–1349.
23. Berdat PA, Immer F, Pfammatter JP, Carrel T. Reoperations in adults
with congenital heart disease: analysis of early outcome. Int J Cardiol.
2004;93:239–245.
24. Oechslin EN, Harrison DA, Harris L, Downar E, Webb GD, Siu SS,
Williams WG. Reoperation in adults with repair of tetralogy of Fallot:
indications and outcomes. J Thorac Cardiovasc Surg. 1999;118:245–251.
25. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM,
McGoon DC, Kirklin JW, Danielson GK. Long-term outcome in patients
undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993;
329:593–599.
26. Giamberti A, Chessa M, Abella R, Butera G, Carlucci C, Nuri H, Frigiola
A, Ranucci M. Morbidity and mortality risk factors in adults with con-
genital heart disease undergoing cardiac reoperations. Ann Thorac Surg.
2009;88:1284–1289.
27. Wauthy P, Massaut J, Sanoussi A, Demanet H, Morissens M, Damry N,
Dessy H, Malekzadeh-Milani SG, Deuvaert FE. Ten-year experience with
surgical treatment of adults with congenital cardiac disease. Cardiol
Young. 2011;21:39–45.
2200 Circulation November 15, 2011
 at Vrije Universiteit--Amsterdam on April 3, 2012http://circ.ahajournals.org/Downloaded from 
28. Cecconi M, Nistri S, Quarti A, Manfrin M, Colonna PL, Molini E, Perna
GP. Aortic dilatation in patients with bicuspid aortic valve. J Cardiovasc
Med (Hagerstown). 2006;7:11–20.
29. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany
J. Clinical and pathophysiological implications of a bicuspid aortic
valve. Circulation. 2002;106:900 –904.
30. Engelfriet PM, Boersma E, Tijssen JG, Bouma BJ, Mulder BJ. Beyond
the root: dilatation of the distal aorta in Marfan’s syndrome. Heart.
2006;92:1238–1243.
31. Meijboom LJ, Timmermans J, Zwinderman AH, Engelfriet PM, Mulder
BJ. Aortic root growth in men and women with the Marfan’s syndrome.
Am J Cardiol. 2005;96:1441–1444.
32. Somerville J. The Denolin Lecture: the woman with congenital heart
disease. Eur Heart J. 1998;19:1766–1775.
33. Vriend JW, Mulder BJ. Late complications in patients after repair of
aortic coarctation: implications for management. Int J Cardiol. 2005;101:
399–406.
34. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD.
Mortality associated with congenital heart defects in the United States:
trends and racial disparities, 1979 –1997. Circulation. 2001;103:
2376–2381.
35. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A.
Prevalence of congenital heart defects in metropolitan Atlanta,
1998–2005. J Pediatr. 2008;153:807–813.
36. Mavroudis C, Jacobs JP. Congenital Heart Surgery Nomenclature and
Database Project: overview and minimum dataset. Ann Thorac Surg.
2000;69:S2–S17.
CLINICAL PERSPECTIVE
A significant proportion of patients with congenital heart disease require surgery in adulthood. In the Congenital Corvitia
(CONCOR) national registry of adults with congenital heart disease, one fifth required surgery during 15 years of
follow-up, and in nearly 40%, surgery was for reoperations. This is the first study showing that men with congenital heart
disease have a 40% higher chance of undergoing first surgery and a 20% higher chance of undergoing reoperations in
adulthood compared with women. Furthermore, men have a 2-times-higher risk of mortality after reoperations in adulthood
compared with women. This study supports the existing evidence for sex differences in the prognosis of adults with
congenital heart disease, and these findings underscore the need for further research on the mechanisms underlying these
differences.
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